These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32438236)

  • 1. Intraductal papillary neoplasm of the bile duct (IPNB): CT and MRI appearance with radiology-pathology correlation.
    Aslam A; Wasnik AP; Shi J; Sahai V; Mendiratta-Lala M
    Clin Imaging; 2020 Oct; 66():10-17. PubMed ID: 32438236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological classification of intraductal papillary neoplasm of the bile duct.
    Ying S; Ying M; Liang W; Wang Z; Wang Q; Chen F; Xiao W
    Eur Radiol; 2018 Apr; 28(4):1568-1578. PubMed ID: 29138880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premalignant lesions of cholangiocarcinoma: characteristics on ultrasonography and MRI.
    Siripongsakun S; Sapthanakorn W; Mekraksakit P; Vichitpunt S; Chonyuen S; Seetasarn J; Bhumiwat S; Sricharunrat T; Srittanapong S
    Abdom Radiol (NY); 2019 Jun; 44(6):2133-2146. PubMed ID: 30820627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
    Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
    Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI.
    Lee S; Kim MJ; Kim S; Choi D; Jang KT; Park YN
    J Hepatol; 2019 Apr; 70(4):692-699. PubMed ID: 30553839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of CT and MRI in distinguishing intraductal papillary neoplasm of the bile duct from cholangiocarcinoma with intraductal papillary growth.
    Liu Y; Zhong X; Yan L; Zheng J; Liu Z; Liang C
    Eur Radiol; 2015 Jul; 25(7):1967-74. PubMed ID: 25716939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound Findings of Intraductal Papillary Neoplasm in Bile Duct and the Added Value of Contrast-Enhanced Ultrasound.
    Liu LN; Xu HX; Zheng SG; Sun LP; Guo LH; Zhang YF; Xu JM; Liu C; Xu XH
    Ultraschall Med; 2015 Dec; 36(6):594-602. PubMed ID: 25188491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas.
    Komori T; Inoue D; Zen Y; Yoneda N; Kitao A; Kozaka K; Yokka A; Toshima F; Matsubara T; Kobayashi S; Gabata T
    Eur Radiol; 2019 Jun; 29(6):3132-3140. PubMed ID: 30519930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal papillary neoplasm of the bile duct: diagnostic value of MRI features in differentiating pathologic subclassifications-type 1 versus type 2.
    Jeon SK; Lee JM; Yoo J; Park S; Joo I; Yoon JH; Lee KB
    Eur Radiol; 2024 Jul; 34(7):4674-4685. PubMed ID: 38114846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No communication between the bile duct and intraductal papillary neoplasm of the bile duct on imaging.
    Chen J; Guan P; Sun P; Yu Q; Yuan H
    Clin Hemorheol Microcirc; 2024; 88(2):129-134. PubMed ID: 38669523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
    Jung G; Park KM; Lee SS; Yu E; Hong SM; Kim J
    J Hepatol; 2012 Oct; 57(4):787-93. PubMed ID: 22634127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of Preoperative
    Ikeno Y; Seo S; Yamamoto G; Nakamoto Y; Uemoto Y; Fuji H; Yoshino K; Yoh T; Taura K; Uemoto S
    Anticancer Res; 2018 Jun; 38(6):3677-3682. PubMed ID: 29848727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Magnetic resonance imaging features and classification of intraductal papillary neoplasm of the bile duct].
    Liu LC; Chen YF; Shan YQ; Chen LL; Zeng MS; Wang ML
    Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):461-468. PubMed ID: 38858196
    [No Abstract]   [Full Text] [Related]  

  • 14. CT findings of intraductal papillary neoplasm of the bile duct: assessment with multiphase contrast-enhanced examination using multi-detector CT.
    Ogawa H; Itoh S; Nagasaka T; Suzuki K; Ota T; Naganawa S
    Clin Radiol; 2012 Mar; 67(3):224-31. PubMed ID: 21944774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Tumor Location on Postoperative Outcome of Intraductal Papillary Neoplasm of the Bile Duct.
    Matsumoto T; Kubota K; Hachiya H; Sakuraoka Y; Shiraki T; Shimizu T; Mori S; Iso Y; Kato M; Yamagishi H; Imai Y; Aoki T
    World J Surg; 2019 May; 43(5):1313-1322. PubMed ID: 30659344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal papillary neoplasm of the bile duct extending superficially from the intrahepatic to extrahepatic bile duct.
    Nanashima A; Sumida Y; Tamaru N; Nakanuma Y; Abo T; Tanaka K; Sawai T; Yasutake T; Nagayasu T; Hayashi T; Fukuda Y
    J Gastroenterol; 2006 May; 41(5):495-9. PubMed ID: 16799893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects.
    Lim JH; Zen Y; Jang KT; Kim YK; Nakanuma Y
    AJR Am J Roentgenol; 2011 Nov; 197(5):1111-20. PubMed ID: 22021503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of diagnosis and therapy for intraductal papillary neoplasm of the bile duct.
    Sakai Y; Ohtsuka M; Sugiyama H; Mikata R; Yasui S; Ohno I; Iino Y; Kato J; Tsuyuguchi T; Kato N
    World J Gastroenterol; 2021 Apr; 27(15):1569-1577. PubMed ID: 33958844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraductal Papillary Neoplasm of the Bile Duct: Clinical, Imaging, and Pathologic Features.
    Park HJ; Kim SY; Kim HJ; Lee SS; Hong GS; Byun JH; Hong SM; Lee MG
    AJR Am J Roentgenol; 2018 Jul; 211(1):67-75. PubMed ID: 29629808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
    Sasaki M; Sato Y
    Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.